Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Am J Med Genet B Neuropsychiatr Genet. 2018 Apr 6;180(2):159–171. doi: 10.1002/ajmg.b.32629

Table I.

Anti-discrimination protections for psychiatric risk biomarkers. Legislative pieces were interpreted based on clearly stated protection in employment, health, life insurance, and disability insurance.

International Anti-Discrimination Legislation Relevant to Psychiatric Risk Biomarkers Social Spheres Protected

Protections for genomics-based psychiatric risk biomarkers Employment Health
Insurance
Life
Insurance
Disability
Insurance

Country Legislation Title Year
Austria Austrian Gene Technology Act 1995
Belgium Insurance Law 1992
The Anti-Discrimination Law 2007
Bulgaria Bulgarian Health Act 2004
Canada Genetic Non-Discrimination Act 2017
Denmark Health Act No. 546 2005
Estonia Human Genes Research Act 2000
France Act of 4 March 2002 2002
Germany Human Genetic Examination Act 2010 * *
Israel Genetic Information Law of 2000 2000
Mexico Federal Law to Prevent and Eliminate Discrimination 2014
Netherlands Medical Examination Act 1998 ** **
Portugal Law n°12/2005 of 26 January 2005 2005
Spain Spanish Constitution of 1978 1978
Sweden The Genetic Integrity Act 2006
United States Genetic Information Nondiscrimination Act 2008

Protections for all psychiatric risk biomarkers

Country Legislation Title Year

Albania Law n°10 221 on Protection From Discrimination 2010
Switzerland Article 328b of the Code of Obligations 1993
*

Germany prohibits use of genetic information for life and disability insurance contracts up to a pre-specified amount.

**

The Netherlands prohibit use of genetic information for life and disability policies up to a pre-specified amount. (Otlowski et al. 2012)